A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects

NCT07655427 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombus

Interventions

DRUG: SRSD107
DRUG: Placebo

Sponsor

Sirius Therapeutics Co., Ltd.